Goldman, UBS Sidelined in China IPOs

Goldman, UBS Sidelined in China IPOs

Kevin Lee/Bloomberg

ChiNext and Shenzhen’s six-year-old board for small and medium-sized companies have dominated first-time sales in China this year, accounting for a combined 227 of the 241 deals.